Panbela Therapeutics Inc (PBLA) is down Friday morning, with the stock declining -2.53% in pre-market trading to 1.54. PBLA's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 113 out of 146 industries, the stock ranks higher than 0% of stocks. Panbela Therapeutics Inc has fallen 51.83% over the past month, closing at $3.11 on January 6. During this period of time, the stock fell as low as $1.43 and as high as $7.52. PBLA has an average analyst recommendation of Buy. The company has an average price target of $10.00.
PBLA has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on PBLA!